153 related articles for article (PubMed ID: 19382571)
1. Column liquid chromatography-ultraviolet and column liquid chromatography/mass spectrometry evaluation of stress degradation behavior of escitalopram oxalate.
Dhaneshwar SR; Mahadik MV; Kulkarni MJ
J AOAC Int; 2009; 92(1):138-47. PubMed ID: 19382571
[TBL] [Abstract][Full Text] [Related]
2. LC-UV and LC-MS evaluation of stress degradation behaviour of tenatoprazole.
Mahadik M; Bhusari V; Kulkarni M; Dhaneshwar S
J Pharm Biomed Anal; 2009 Dec; 50(5):787-93. PubMed ID: 19615841
[TBL] [Abstract][Full Text] [Related]
3. Stability-indicating RP-HPLC method for the simultaneous determination of escitalopram oxalate and clonazepam.
Kakde RB; Satone DD; Gadapayale KK; Kakde MG
J Chromatogr Sci; 2013 Jul; 51(6):490-5. PubMed ID: 23135233
[TBL] [Abstract][Full Text] [Related]
4. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
Bhardwaj SP; Singh S
J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751
[TBL] [Abstract][Full Text] [Related]
5. HPLC and LC-MS studies on stress degradation behaviour of tinidazole and development of a validated specific stability-indicating HPLC assay method.
Bakshi M; Singh S
J Pharm Biomed Anal; 2004 Jan; 34(1):11-8. PubMed ID: 14738914
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of stress degradation products of febuxostat employing ultra-performance liquid chromatography-ultraviolet/photodiode array and liquid chromatography-mass spectrometry/time-of-flight studies.
Saha M; Bali A; Patra SR; Singh J
Rapid Commun Mass Spectrom; 2023 Jan; 37(2):e9423. PubMed ID: 36278931
[TBL] [Abstract][Full Text] [Related]
7. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
[TBL] [Abstract][Full Text] [Related]
8. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
Kumar N; Sangeetha D; Reddy SP
J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
[TBL] [Abstract][Full Text] [Related]
9. Study of forced degradation behaviour of florfenicol by LC and LC-MS and development of a validated stability-indicating assay method.
Mistiri F; Louati K; Grissa O; Kallel M; Safta F
Ann Pharm Fr; 2012 Nov; 70(6):333-47. PubMed ID: 23177560
[TBL] [Abstract][Full Text] [Related]
10. Fesoterodine stress degradation behavior by liquid chromatography coupled to ultraviolet detection and electrospray ionization mass spectrometry.
Sangoi MS; Todeschini V; Steppe M
Talanta; 2011 May; 84(4):1068-79. PubMed ID: 21530781
[TBL] [Abstract][Full Text] [Related]
11. Forced degradation of fingolimod: effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF-MS/MS and 1H NMR.
Patel PN; Kalariya PD; Gananadhamu S; Srinivas R
J Pharm Biomed Anal; 2015 Nov; 115():388-94. PubMed ID: 26279369
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
[TBL] [Abstract][Full Text] [Related]
13. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
[TBL] [Abstract][Full Text] [Related]
14. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
[TBL] [Abstract][Full Text] [Related]
15. Identification, characterisation and in silico ADMET prediction of ozenoxacin and its degradation products using high-performance liquid chromatography-photodiode array and liquid chromatography-quadrupole time-of-flight-tandem mass spectrometry.
Matta A; Sundararajan R
Rapid Commun Mass Spectrom; 2024 Feb; 38(3):e9676. PubMed ID: 38211348
[TBL] [Abstract][Full Text] [Related]
16. Analytical method development, identification, and characterization of stress degradation products of idelalisib by ultrahigh-performance liquid chromatography with photodiode array and ultrahigh-performance liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry studies.
Mahesh M; Bali A; Gupta T
Rapid Commun Mass Spectrom; 2024 Jun; 38(11):e9745. PubMed ID: 38591150
[TBL] [Abstract][Full Text] [Related]
17. LC and LC-MS/MS studies for identification and characterization of degradation products of d-tubocurarine chloride.
Grover P; Maheshwari S; Nagarajan K; Mehta L; Kumar S; Rastogi C
J Pharm Biomed Anal; 2023 Jan; 223():115119. PubMed ID: 36343537
[TBL] [Abstract][Full Text] [Related]
18. LC-MS/MS characterization of forced degradation products of zofenopril.
Ramesh T; Nageswara Rao P; Nageswara Rao R
J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
[TBL] [Abstract][Full Text] [Related]
19. LC and LC-MS/TOF studies on stress degradation behaviour of candesartan cilexetil.
Mehta S; Shah RP; Priyadarshi R; Singh S
J Pharm Biomed Anal; 2010 Jul; 52(3):345-54. PubMed ID: 19505786
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive study on degradation profile of firocoxib and structural elucidation of its key degradation products.
Adhikari S; Tian J; Rustum AM
J Pharm Biomed Anal; 2023 Feb; 224():115192. PubMed ID: 36463770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]